(Total Views: 678)
Posted On: 01/26/2021 9:10:37 PM
Post# of 154703
It seems to me that Dr Patterson's presentation today, regarding leronlimab:
1) is not being perceived as being as "significant" as it should be, and
2) reveals leronlimab to be an "amazing" therapeutic for m/m & s/c covid-19
https://drive.google.com/drive/folders/1yb8wG...obJla6LaB4
His longhauler presentation does not emphasize leronlimab, I'm not sure if he even mentions it.
But for m/m and s/c covid-19, leronlimab is the dominant topic in his presentation and the dominant topic in his slide presentation. The potential for leronlimab for fighting this pandemic (per his entire presentation) should be viewed by those in attendance, and by any who review his presentation, as being very very strong,
Surely most of the doctors present, are probably not focused on seeking investment opportunites, but it seems they should now be asking about and doing some research on leronlimab
1) is not being perceived as being as "significant" as it should be, and
2) reveals leronlimab to be an "amazing" therapeutic for m/m & s/c covid-19
https://drive.google.com/drive/folders/1yb8wG...obJla6LaB4
His longhauler presentation does not emphasize leronlimab, I'm not sure if he even mentions it.
But for m/m and s/c covid-19, leronlimab is the dominant topic in his presentation and the dominant topic in his slide presentation. The potential for leronlimab for fighting this pandemic (per his entire presentation) should be viewed by those in attendance, and by any who review his presentation, as being very very strong,
Surely most of the doctors present, are probably not focused on seeking investment opportunites, but it seems they should now be asking about and doing some research on leronlimab
(11)
(0)
